Clinical trials
Rabies trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
95 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 3 |
| 2004 | 1 |
| 2006 | 1 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 3 |
| 2011 | 6 |
| 2012 | 5 |
| 2013 | 5 |
| 2014 | 5 |
| 2015 | 6 |
| 2016 | 4 |
| 2017 | 1 |
| 2018 | 6 |
| 2019 | 7 |
| 2020 | 7 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 3 |
| 2025 | 8 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 65 |
| Unknown status | 11 |
| Not yet recruiting | 9 |
| Terminated | 3 |
| Active, not recruiting | 3 |
| Recruiting | 2 |
| Available | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sanofi Pasteur, a Sanofi Company | 11 |
| Queen Saovabha Memorial Institute | 9 |
| Novartis Vaccines | 6 |
| Sinovac Biotech Co., Ltd | 5 |
| Synermore Biologics (Suzhou) Co., Ltd. | 5 |
| Crucell Holland BV | 3 |
| CureVac | 3 |
| GlaxoSmithKline | 3 |
| Ningbo Rongan Biological Pharmaceutical Co., Ltd. | 3 |
| University of Oxford | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rabies | 95 |
| Virus Diseases | 4 |
| Encephalitis, Japanese | 3 |
| Yellow Fever | 2 |
| COVID-19 | 1 |
| Communicable Diseases | 1 |
| Diarrhea | 1 |
| Encephalitis | 1 |
| Fever | 1 |
| Meningitis, Meningococcal | 1 |
Trials
Showing 26 to 50 of 95. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.